Diversified healthcare company CVS Health (NYSE:CVS) announced better-than-expected revenue in Q1 CY2025, with sales up 7% ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

UnitedHealth Group Incorporated's stock faces a steep decline amid leadership turmoil, regulatory pressures, and rising costs ...

Rite Aid's bankruptcy plan, if approved, means that in the coming months all distribution centers will close, and all stores ...

Big retailers’ ambitions to disrupt healthcare are falling apart. Companies have run into difficulties trying to make ...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

From seasonal pollen to pet dander, understanding your allergies and the treatment options available is critical to finding ...

UnitedHealth remains in fine financial shape. As of December 2024, the company owed $77 billion in debt (held at the parent level), or gross debt/EBITDA of around 2 times. The parent company typically ...

President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

Rite Aid says a few months for most of its stores. All locations will eventually close or be sold to a new owner by the end ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Omada Health, a virtual chronic care provider, filed to go public Friday, marking the second digital health company making ...